Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory

Journal of Infectious Diseases

Volumn 179, Issue 6, 1999, Pages 1569-1572

  Richmond, Peter ^a,b,c,d   Borrow, Ray ^a,b,c   Miller, Elizabeth ^a,b,c   Clark, Sarah ^a,b,c   Sadler, Francesca ^a,b,c   Fox, Andrew ^a,b,c   Begg, Norman ^a,b,c   Morris, Rhonwen ^a,b,c   Cartwright, Keith ^a,b,c  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b WITHINGTON HOSPITAL   (United Kingdom)

^c GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^d Immunisation Division   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; MENINGOCOCCAL C CONJUGATE VACCINE; MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; COMMON COLD; COUGHING; DOSE RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FACE EDEMA; FEVER; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; INFANT; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; PRIORITY JOURNAL; RASH;

BACTERIAL CAPSULES; BACTERIAL VACCINES; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; INFANT; MALE; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; VACCINATION;

EID: 0033033037     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314753     Document Type: Article

References (17)

1. 1. Achtman M. Global epidemiology of meningococcal disease. In: Cartwright K, ed. Meningococcal disease. Chichester, UK: John Wiley & Sons, 1995: 159-75.
2. 2. Ramsay M, Collins M, Rush M, Kaczmarski E. The epidemiology of meningococcal disease in England and Wales, 1996 and 1997. Eurosurveillance 1997;2:74-6.
3. 3. Kaczmarski EB. Meningococcal disease in England and Wales: 1995. Commun Dis Rep CDR Rev 1997;7:R55-9.
4. 4. Gold R, Lepow ML, Goldschneider I, Draper TL, Gotschlich EC. Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants. J Clin Invest 1975;56:1536-47.
5. 5. Taunay AE, Galvao JS, de Morais EC, Gotschlich EC. Disease prevention by meningococcal serogroup C polysaccharide vaccine in pre-school children: results after eleven months in Sao Paulo, Brazil [abstract]. Pediatr Res 1974;8:429.
6. 6. Leach A, Twumasi PA, Greenwood BM, et al. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J Infect Dis 1997;175:200-4.
7. 7. Eskola J, Kayhty H. Ten years' experience with Haemophilus influenzae type b (Hib) conjugate vaccines in Finland. Rev Med Microbiol 1996;7:231-41.
8. 8. Fairley CK, Begg N, Borrow R, Fox AJ, Jones DM, Cartwright K. Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants. J Infect Dis 1996;174:1360-3.
9. 19; conjugate vaccine in adults [abstract]. Clin Infect Dis 1995;21: 790.
10. 10. Department of Health, Welsh Office, Scottish Home and Health Department. Immunisation against infectious disease. 2nd ed. London: Her Majesty's Stationery Office, 1992.
11. 11. Gheesling LL, Carlone GM, Pais L, et al. Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J Clin Microbiol 1994;32:1475-82.
12. 12. Anderson EL, Bowers T, Mink CM, et al. Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults. Infect Immun 1994;62:3391-5.
13. 13. Begg NT, Miller E, Fairley CK, et al. Antibody responses after DTP and either tetanus or diphtheria Haemophilus influenzae type b conjugate vaccines given for primary immunisation by separate or mixed injection. Vaccine 1995;13:1547-50.
14. 14. Goldschneider I, Gotschlich E, Artenstein MS. Humoral immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 1969;129: 1307-26.
15. 15. Peltola H, Mäkelä H, Käyhty H, et al. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children less than three months to five years of age. N Engl J Med 1977;297:686-91.
16. 16. King WJ, MacDonald NE, Wells G, et al. Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children. J Pediatr 1996;128:196-201.
17. 17. Ahman H, Kahyhty H, Lehtonen H, Leroy O, Froeschele J, Eskola J. Streplococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. Pediatr Infect Dis J 1998;17:211-6.